Paratek Pharmaceuticals, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Paratek Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q2 2023.
  • Paratek Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2023 was -$14.6M, a 17.4% increase year-over-year.
  • Paratek Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2023 was -$62.7M, a 27% increase year-over-year.
  • Paratek Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$63.6M, a 7.59% decline from 2021.
  • Paratek Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$59.1M, a 38.8% increase from 2020.
  • Paratek Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$96.5M, a 25% increase from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 -$62.7M -$14.6M +$3.07M +17.4% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-03
Q1 2023 -$65.8M -$20.1M -$2.23M -12.5% Jan 1, 2023 Mar 31, 2023 10-Q 2023-08-03
Q4 2022 -$63.6M -$7.16M +$25.1M +77.8% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-16
Q3 2022 -$88.7M -$20.9M -$2.68M -14.7% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-03
Q2 2022 -$86M -$17.6M -$27.3M -281% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 -$58.6M -$17.9M +$436K +2.38% Jan 1, 2022 Mar 31, 2022 10-Q 2023-08-03
Q4 2021 -$59.1M -$32.3M -$7.24M -29% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-14
Q3 2021 -$51.8M -$18.2M +$2.65M +12.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$54.5M $9.72M +$32.8M Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-03
Q1 2021 -$87.3M -$18.3M +$9.27M +33.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-03
Q4 2020 -$96.5M -$25M +$2.36M +8.61% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-14
Q3 2020 -$98.9M -$20.9M +$11.8M +36.1% Jul 1, 2020 Sep 30, 2020 10-K 2022-03-14
Q2 2020 -$111M -$23.1M +$10.1M +30.5% Apr 1, 2020 Jun 30, 2020 10-K 2022-03-14
Q1 2020 -$121M -$27.6M +$7.99M +22.4% Jan 1, 2020 Mar 31, 2020 10-K 2022-03-14
Q4 2019 -$129M -$27.4M -$4.58M -20.1% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-29
Q3 2019 -$124M -$32.6M -$531K -1.66% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-29
Q2 2019 -$124M -$33.2M -$3.47M -11.7% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-29
Q1 2019 -$120M -$35.6M -$7.86M -28.3% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-29
Q4 2018 -$112M -$22.8M -$897K -4.1% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-10
Q3 2018 -$111M -$32.1M -$10.8M -50.5% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-10
Q2 2018 -$101M -$29.7M -$11.6M -63.5% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-10
Q1 2018 -$89.1M -$27.8M -$80K -0.29% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-10
Q4 2017 -$89.1M -$21.9M +$4.56M +17.2% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-06
Q3 2017 -$93.6M -$21.3M +$2.3M +9.75% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-06
Q2 2017 -$95.9M -$18.2M +$12.1M +40% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-06
Q1 2017 -$108M -$27.7M +$3.6M +11.5% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-06
Q4 2016 -$112M -$26.5M -$5.35M -25.3% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-06
Q3 2016 -$106M -$23.6M -$207K -0.88% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-06
Q2 2016 -$106M -$30.3M -$14.6M -92.9% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-06
Q1 2016 -$91.5M -$31.3M -$20.6M -194% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-06
Q4 2015 -$70.9M -$21.1M -$9.99M -89.8% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-02
Q3 2015 -$60.9M -$23.4M -$20.2M -624% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-02
Q2 2015 -$40.7M -$15.7M -$13.4M -592% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-02
Q1 2015 -$27.3M -$10.6M -$9.42M -778% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-02
Q4 2014 -$17.8M -$11.1M -$5.59M -101% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-09
Q3 2014 -$12.2M -$3.23M +$1.47M +31.3% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-09
Q2 2014 -$13.7M -$2.27M +$4.44M +66.2% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-09
Q1 2014 -$18.2M -$1.21M +$9.29M +88.5% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-09
Q4 2013 -$27.4M -$5.54M +$1.02M +15.5% Oct 1, 2013 Dec 31, 2013 10-K 2014-03-14
Q3 2013 -$28.5M -$4.7M -$9.56M -197% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-28
Q2 2013 -$18.9M -$6.71M -$1.57M -30.5% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-06
Q1 2013 -$17.3M -$10.5M -$5.32M -103% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-05
Q4 2012 -$12M -$6.55M -$11.9M -224% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-14
Q3 2012 -$166K $4.86M +$9.85M Jul 1, 2012 Sep 30, 2012 10-K 2014-03-14
Q2 2012 -$10M -$5.14M -$2.89M -129% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-14
Q1 2012 -$7.12M -$5.18M -$3.24M -167% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-14
Q4 2011 -$3.88M $5.3M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-12
Q3 2011 -$4.99M -$2.22M -80.4% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-12
Q2 2011 -$2.25M -$185K -8.98% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-12
Q1 2011 -$1.94M Jan 1, 2011 Mar 31, 2011 10-K 2013-03-12
Q3 2010 -$2.77M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-10
Q2 2010 -$2.06M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.